The Key to Spinal Cord Recovery: Harnessing p21 Inhibition to Boost Neural Stem/Progenitor Cell Proliferation.

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biotechnology

Background:

• Spinal cord injury (SCI) causes irreversible neurological deficits by limiting neural stem/progenitor cell (NSPC) proliferation.
• Upregulation of p21 is identified as a key factor inhibiting NSPC proliferation post-SCI.

Purpose of the Study:

• To develop a novel delivery system to enhance NSPC proliferation for spinal cord regeneration.
• To investigate the therapeutic potential of targeting p21 in SCI.

Main Methods:

• Development of a cationic liposome encapsulating p21 small interfering RNA (siRNA) for NSPC delivery (P21siRNA@LP).
• In vitro assessment of NSPC proliferation and differentiation capacity.
• Transcriptomic and functional analysis of P21siRNA@LP effects on NSPCs.
• In vivo evaluation of P21siRNA@LP in a rat T9 SCI model using gelatin hydrogels.

Main Results:

• P21siRNA@LP significantly increased NSPC proliferation rates in vitro (145.4% on day 1, 144.7% on day 3) while preserving differentiation.
• P21siRNA@LP modulated cyclin-dependent kinases, enhancing cell cycle pathways and promoting extracellular matrix reorganization and gliogenesis.
• In vivo, P21siRNA@LP in hydrogels facilitated NSPC migration and proliferation at lesion sites, promoting dense tissue cable formation and accelerating locomotor recovery in SCI rats.

Conclusions:

• Targeting p21 via siRNA delivery is a viable strategy to enhance NSPC proliferation and promote spinal cord regeneration.
• This liposome-based system offers a promising platform for CNS repair therapies.
• Cell cycle manipulation presents a potential therapeutic approach for treating central nervous system disorders.